Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 13:415:39-47.
doi: 10.1016/j.carres.2015.07.005. Epub 2015 Jul 23.

S-Ribosylhomocysteine analogs containing a [4-thio]ribose ring

Affiliations

S-Ribosylhomocysteine analogs containing a [4-thio]ribose ring

Adam J Sobczak et al. Carbohydr Res. .

Abstract

The [4-thio]-S-ribosylhomocysteine (SRH) analogs containing substitution of a sulfur atom for the endocyclic oxygen were synthesized by coupling of the 4-thioribose substrates with a thiolate generated from the protected homocysteine. Coupling of the protected 1-deoxy-5-O-mesyl-S-oxo-4-thio-D-ribofuranose with homocysteinate salt gave the C4 epimers of [4-thio]-SRH at the sulfoxide oxidation level lacking a hydroxyl group at anomeric carbon. Treatment of these sulfoxides with BF3⋅Et2O/NaI affected simultaneous reduction to sulfide and global deprotection affording 1-deoxy-4-thio-SRH analog. Treatment of the protected 1-deoxy-S-oxo-4-thio-D-ribofuranose sulfoxide with DAST/SbCl3 resulted in the fluoro-Pummerer rearrangement to give 4-thio-β-D-ribofuranosyl fluoride. Mesylation of the latter at 5-hydroxyl position followed by coupling with homocysteinate salt and subsequent global deprotection with trifluoroacetic acid afforded [4-thio]-SRH thiohemiacetal.

Keywords: Homocysteine; LuxS; S-Ribosylhomocysteine; Thioacetals; Thiosugars.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biosynthetic pathway to AI-2. Enzymatic conversion of SRH to DPD by LuxS.
Figure 2
Figure 2
1-Deoxy and 4-aza analogues of S-ribosylhomocysteine.,
Scheme 1
Scheme 1
Reagents and conditions: (a) MCPBA/CH2Cl2/-78°C; (b) MsCl/Et3N/CH2Cl2; (c) LDA/DMF; (d) BocNHCH(CHCHSH)CO2t-Bu/LDA/DMF; (e) TFA/H2O; (f) BF3/Et2O/NaI/CH3CN.
Scheme 2
Scheme 2
Reagents and conditions: (a) Ac2O/DMAP; (b) MCPBA/CH2Cl2/-78°C; (c) DAST/SbCl3/CH2Cl2/55°C; (d) NH3/MeOH; (e) MsCl/Et3N/CH2Cl2; (f) BocNHCH(CHCHSH)CO2t-Bu/LDA/DMF; (g) H2O/H+; (h) TFA/H2O (9:1).
Scheme 3
Scheme 3
Reagents and conditions: (a) Ac2O/100 °C/6 h; (b) MCPBA/CH2Cl2/-78 °C; (c) MsCl/Et3N/CH2Cl2; (d) NH3/MeOH

References

    1. Waters CM, Bassler BL. Annu Rev Cell Dev Biol. 2005;21:319–346. - PubMed
    1. Camilli A, Bassler BL. Science. 2006;311:1113–1116. - PMC - PubMed
    1. Lebeer S, De Keersmaecker SCJ, Verhoeven TLA, Fadda AA, Marchal K, Vanderleyden J. J Bacteriol. 2007;189:860–871. - PMC - PubMed
    1. Ni N, Li M, Wang J, Wang B. Med Res Rev. 2009;29:65–124. - PubMed
    1. Mattmann ME, Blackwell HE. J Org Chem. 2010;75:6737–6746. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources